chr10-18140695-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_201596.3(CACNB2):c.-42C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0357 in 1,559,106 control chromosomes in the GnomAD database, including 1,150 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.042 ( 150 hom., cov: 32)
Exomes 𝑓: 0.035 ( 1000 hom. )
Consequence
CACNB2
NM_201596.3 5_prime_UTR
NM_201596.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.990
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 10-18140695-C-A is Benign according to our data. Variant chr10-18140695-C-A is described in ClinVar as [Benign]. Clinvar id is 190719.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0597 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNB2 | ENST00000324631 | c.-42C>A | 5_prime_UTR_variant | 1/14 | 1 | NM_201596.3 | ENSP00000320025.8 | |||
CACNB2 | ENST00000352115.10 | c.-42C>A | upstream_gene_variant | 1 | ENSP00000344474.6 | |||||
CACNB2 | ENST00000377328.5 | c.-42C>A | upstream_gene_variant | 1 | ENSP00000366545.1 | |||||
CACNB2 | ENST00000645287.2 | c.-485C>A | upstream_gene_variant | ENSP00000496203.1 |
Frequencies
GnomAD3 genomes AF: 0.0420 AC: 6384AN: 152086Hom.: 149 Cov.: 32
GnomAD3 genomes
AF:
AC:
6384
AN:
152086
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0326 AC: 5979AN: 183408Hom.: 131 AF XY: 0.0332 AC XY: 3332AN XY: 100470
GnomAD3 exomes
AF:
AC:
5979
AN:
183408
Hom.:
AF XY:
AC XY:
3332
AN XY:
100470
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0350 AC: 49223AN: 1406906Hom.: 1000 Cov.: 27 AF XY: 0.0353 AC XY: 24619AN XY: 697748
GnomAD4 exome
AF:
AC:
49223
AN:
1406906
Hom.:
Cov.:
27
AF XY:
AC XY:
24619
AN XY:
697748
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0420 AC: 6390AN: 152200Hom.: 150 Cov.: 32 AF XY: 0.0413 AC XY: 3072AN XY: 74416
GnomAD4 genome
AF:
AC:
6390
AN:
152200
Hom.:
Cov.:
32
AF XY:
AC XY:
3072
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
56
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 25, 2013 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at